Terminated PHASE2 INTERVENTIONAL 1-arm NCT00807365

Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly (PP2)

Six Month Treatment of GHRH in the Elderly

Sponsor: Johns Hopkins University

Conditions Elderly

Interventions GHRH

Updated 7 times since 2017 Last updated: Mar 16, 2017 Started: Dec 17, 2007 Primary completion: Apr 29, 2010 Completion: Apr 29, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

PI left JHU

Other terminated trials from Johns Hopkins University

See all terminations from Johns Hopkins University

Listed as NCT00807365, this PHASE2 trial focuses on Elderly and remains terminated or withdrawn. Sponsored by Johns Hopkins University, it has been updated 7 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jun 2017 — Jun 2018 [monthly]

Terminated PHASE2

Status: Unknown Status → Terminated

▶ Show 2 earlier versions

Feb 2017 — Jun 2017 [monthly]

Unknown Status PHASE2
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE2

First recorded

Dec 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johns Hopkins University
Massachusetts General Hospital

Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States
• Boston, United States